Altimmune (ALT) had the highest return in 2009 and on December 30, 2009 by a small-cap US stock, returning 66.7%.
| ASSET | % RETURN |
|---|---|
Altimmune (ALT) | 66.67% |
Applied Digital (APLD) | 33.33% |
Saratoga Investment (SAR) | 16.66% |
Sapiens International (SPNS) | 12.78% |
Harrow Health (HROW) | 11.11% |
Bel Fuse A (BELFA) | 10.5% |
Anavex Life Sciences (AVXL) | 10% |
Gravity (GRVY) | 9.68% |
Avino Silver & Gold Mines (ASM) | 8.79% |
Shyft (SHYF) | 7.8% |
Heron Therapeuti (HRTX) | 7.75% |
SIGA Technologies (SIGA) | 7.75% |
Willdan (WLDN) | 6.94% |
Bel Fuse B (BELFB) | 6.52% |
Avadel Pharmaceuticals (AVDL) | 6.18% |
Hackett (HCKT) | 5.97% |
Imax (IMAX) | 5.76% |
Seneca Foods Corp B (SENEB) | 5.53% |
Addus HomeCare (ADUS) | 5.26% |
North American Construction (NOA) | 5.22% |
ChipMOS Technologies (IMOS) | 5.04% |
Cross Country Healthcare (CCRN) | 4.93% |
Smith & Wesson Brands (SWBI) | 4.86% |
Gilat Satellite Networks (GILT) | 4.63% |
Horizon Bancorp (HBNC) | 4.61% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
